- Home
- Products
- Customized ADCs
- TM4SF1
- Anti-TM4SF1 ( clone v1.10)-Mc-LP2 ADC
Anti-TM4SF1 ( clone v1.10)-Mc-LP2 ADC (CAT#: ADC-W-517)
This ADC product is comprised of an anti-TM4SF1 monoclonal antibody (clone v1.10) conjugated via a Mc linker to LP2.
- Product Information
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Antibody clone #
- V1.10
- Similar to
- v1.10-LP2
- Name
- TM4SF1
- Alternative Names
- TM4SF1; transmembrane 4 L six family member 1; L6; H-L6; M3S1; TAAL6; transmembrane 4 L6 family member 1; tumor-associated antigen L6; transmembrane 4 superfamily member 1; membrane component chromosome 3 surface marker 1; membrane component, chromosome 3
- Target Entrez Gene ID
- 4071
- Target UniProt ID
- P30408
- Overview
- The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface antigen and is highly expressed in different carcinomas. [provided by RefSeq, Jul 2008]
- Overview
- Humanized Anti-TM4SF1 Antibody, clone # v1.10
- Clone #
- V1.10
- Species Reactivity
- Human
- Name
- Mc (maleimidocaproyl)
- Description
- Noncleavable linkers, is considered noncleavable-meaning linker cleavage, and payload release does not depend on the differential properties between the plasma and some cytoplasmic compartments. Instead, the release of the cytotoxic drug is postulated to occur after internalization of the ADC via antigen-mediated endocytosis and delivery to lysosomal compartment, where the antibody is degraded to the level of amino acids through intracellular proteolytic degradation.
- Name
- LP2 (chemical name mc-3377)
- Description
- Derived from Auristatin,are water-soluble dolastatin analogs of dolastatin 10. Dolastatin 10 belongs to dolastatin family and it can powerfully bind to tubulin, thus inhibiting polymerization mediated through the binding to the vinca alkaloid binding domain, and causes cell to accumulate in metaphase arrest.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-IL9 (Enokizumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1452)
- Anti-IL4 (Pascolizumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1380)
- Anti-CD56 (clone huN901)-SMCC-[3H]DM1 ADC (CAT#: ADC-W-598)
- Anti-TNFRSF17 (clone CA8 J6M2)-VC-MMAE ADC (CAT#: ADC-W-268)
- Anti-EPCAM (Citatuzumab bogatox)-MC-MMAF ADC (CAT#: ADC-W-1078)
- Anti-IFNAR (Anifrolumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-2058)
- Anti-MSLN ( MMOT-0530A)-MMAE ADC (CAT#: ADC-W-442)
- Anti-TNFRSF8 (Iratumumab)-SPDB-DM4 ADC (CAT#: ADC-W-1887)
- Anti-CXCR4 (Ulocuplumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-1927)
- Anti-ITGB2 (Erlizumab)-MC-MMAF ADC (CAT#: ADC-W-1510)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-517. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
CAT# | Product Name | Linker | Payload |
ADC-W-518 | Anti-TM4SF1 ( clone 2A7A)-Mc-LP2 ADC | Mc (maleimidocaproyl) | LP2 (chemical name mc-3377) |
CAT# | Product Name | Linker | Payload |
ADC-W-2606 | Anti-ITGB3 (Tadocizumab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
ADC-W-2600 | Anti-GPNMB (Glembatumumab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
ADC-W-518 | Anti-TM4SF1 ( clone 2A7A)-Mc-LP2 ADC | Mc (maleimidocaproyl) | LP2 (chemical name mc-3377) |
ADC-W-537 | Anti-TPBG-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
ADC-W-485 | Anti-EphA2 (clone 1C1)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
CAT# | Product Name | Linker | Payload |
ADC-W-518 | Anti-TM4SF1 ( clone 2A7A)-Mc-LP2 ADC | Mc (maleimidocaproyl) | LP2 (chemical name mc-3377) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.